Mathieu Uzzan
@mat_uzz
Followers
276
Following
2K
Media
15
Statuses
539
Physician-scientist #IBD #immunology #MondorMICI
Paris
Joined June 2009
#CGH4ALL @AGA_CGH Breast cancer is the most common malignancy🚨 in IBD. This study evaluated the risk factors for incident cancer in IBD w/ hx of breast Ca. 🔗 https://t.co/FhZTHBucoT Summary by @NAggarwalMD
@J_Kirchgesner @Pseksik @AlexandreNuzzo @snancey1 @MatFume @mat_uzz
0
8
27
👩⚕️👨⚕️Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis ▪︎GETAID multi🏥 retrospective study ▪︎N=169 pts ▪︎SFCR at weeks 8-14: upadacitinib (55.2%) 🆚️filgotinib (33.3%)🆚️tofacitinib (50%) ▪︎upa was associated with ⬆️ odds of SFCR compared to Filgo
2
16
48
Join us ! Open #Postdoc position in my lab (Paris, France), to work on the Role of the Gut #microbiota in Host Cells Energy Metabolism in Health and #IBD see details here 🔽🔽🔽🔽 https://t.co/nUv6slIV6k please RT
1
29
50
What an absolute honour and privilege to host Prof. Harry Sokol @h_sokol at the University of Calgary as part of the @SnyderInstitute endowed chair series . A packed auditorium listening to a masterful talk on the gut microbiota and IBD. Harry is trailblazing the field .
1
5
27
🌟 The #ECCO topical review on IBD Predictive Models has been published in @JCC_IBD! 🔍 In this review, we 1️⃣ Summarized all current models 2️⃣ Identified relevant methodology 3️⃣ Provided guidance for future models 🙏 Huge thanks to the team! https://t.co/pU2B5IwNaW
0
12
22
Elles sont médecins, chercheuses et scientifiques à @GustaveRoussy. 💬 « J'ai été baignée dans cet univers féminin, avec ces femmes très fortes et très brillantes. » À l'occasion de la Journée internationale des femmes et des filles de science, découvrez le portrait de la Dr
0
8
21
Congrats SURVI guys
1st patient included in the 1st randomized controlled trial in acute mesenteric ischemia! “ORal antibiotics In Acute Mesenteric Ischemia: a multicenter randomized controlled trial” #ORIAMI @AlexandreNuzzo @APHP #FHUTSUNAMI @oliviercorcos #SURVI @UP_Medecine
0
0
0
1/3 Thrilled to share exciting new work in @Nature by @TouficMayassi, @li_chenhao, Åsa Segerstolpe, et al. Spatial profiling of mouse intestine reveals a landscape robust to perturbations in homeostatic drivers & adaptable in a spatially-restricted manner
nature.com
Nature - Intestinal regionalization is characterized by robust and resilient structural cell states and the intestine can adapt to environmental stress in a spatially controlled manner through...
0
31
105
📢Thrilled to share our work on the ontogeny, reactivity, and function of #IgA subclasses in homeostasis and #IBD! Huge thanks to Andrea, all our amazing collaborators, and @JExpMed for their support throughout the extended revision process! It's time to celebrate🥳!
Tejedor Vaquero, Neuman, Mehr, Cerutti, @GMagri_Immuno @HMar_research et al. show that gut IgA1 & IgA2 subclasses co-emerge early in life, largely derive from clonally related and somatically mutated plasma cells in adults, & show unique changes in #IBS. https://t.co/B7u4GIs7Vg
3
13
36
Happy to participate to this important and great team effort with incredible European colleagues and patients representatives @Y_ECCO_IBD !
0
1
13
Very happy this publication officially kicks off the @CollibriIbd consortium. Let’s continu collaborative research to move the needle for the benefit of our patients !
Characterisation of #IBD #heterogeneity using serum #proteomics, a first study by the @CollibriIbd consortium. A multicentre study by Salomon and Sudhakar et al. @jonashalfvarson @SeverineVermei1 @bverstockt
https://t.co/xYugUrMlgo
2
8
47
Please RT 🙏!📢My lab at @UniBarcelona is seeking a highly motivated postdoc to lead an exciting new public-private collaborative project (UB, CRG, CSIC, OrikineBio) aimed at testing a potentially game-changing therapy for IBD. If interested, please contact me at gmagri@ub.edu.
0
11
7
Congrats! Huge achievement 👏 👏
Delighted to announce that I've been awarded an @ERC_Research Starting Grant of ~1.5M € for my project FORECAST. I will develop in the next 5y a new framework using multiple sources of #RWD to assess the benefit-risk balance of #IBD treatments. #ERCStG
https://t.co/L00ZWZ0TSN
0
0
2
Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: the ERIC study CD patients from Saint-Antoine and Beaujon Hospital comparing Early vs Late resections https://t.co/HMzNko2fhC
@APandT
@PSeksik @J_Kirchgesner @h_sokol
6
15
56
A true legend ⭐️
Today marks the last day of Laurent Beaugerie at @HopSaintAntoine. An #IBD legend is retiring after more than 40 years at @APHP. Immensely grateful for his mentorship and support since 15 years. Stay tuned for his new exciting professional chapter!
1
1
7
Le Séminaire GETAID-REMIND aura lieu le jeudi 5 décembre et le vendredi 6 décembre 2024 ! 🎉 Les inscriptions sont ouvertes 😃
1
4
4
Les inscriptions pour la Masterclass du GETAID sont lancées ! 🥳 Au programme : mises au point, échanges avec les experts, ateliers,... Le programme complet disponible ici : https://t.co/0Ewklhs5l5
0
2
2
@guthealthmd @NickPowellLab @ibdgc @NIDDKgov @MatthieuAllez Not sure about FMT, but, with @MatthieuAllez and the #REMIND group, we will soon start a study evaluating the effects of Faecalibacterium prausnitzii in postoperative settings
0
2
8